Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Joseph Fresquez"'
Autor:
Linghua Wang, Jeffrey Myers, Michelle Williams, Alexandre Reuben, Michael Curran, Neil Gross, Diana Bell, Xiuning Le, Maura Gillison, Minghao Dang, Amit Agrawal, Stephen Lai, Ryan Goepfert, Qianyun Luo, Ravaen Slay, Venkatesh Hegde, Weihong Xiao, Keiko Akagi, Joseph Fresquez, Kathrina Marcelo, Pragya Sinha, Ananta Yanamandra, Edwin Parra Cuentas, Jagannadha Sastry
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/1c3d1499abc047e3af293089c60c7bf9
Autor:
Xiuning Le, Minghao Dang, Venkatesh L. Hegde, Bo Jiang, Ravaen Slay, Weihong Xiao, Keiko Akagi, Joseph Fresquez, Kathrina L. Marcelo, Qianyun Luo, Pragya Sinha, Ananta V. Yanamandra, Joe Dan Dunn, Diana Bell, Michelle Williams, Edwin Parra, Ryan Goepfert, Stephen H. Lai, Neil Gross, Amit Agrawal, Alexandre Reuben, Jeffrey Myers, Michael A. Curran, K. Jagannadha Sastry, Linghua Wang, Maura L. Gillison
The authors have withdrawn their manuscript because a major revision is in progress to incorporate additional data. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef65d3876e88b562fd9139ddc404a426
https://doi.org/10.1101/2021.12.02.21266776
https://doi.org/10.1101/2021.12.02.21266776
Autor:
Edwin Roger Parra Cuentas, Ravaen B Slay, Qianyun Luo, Ryan P. Goepfert, Diana Bell, Michelle A. Williams, Minghao Dang, Keiko Akagi, Kathrina Marcelo, Alexandre Reuben, Weihong Xiao, Michael A. Curran, Joseph Fresquez, Bo Jiang, Jagannadha K. Sastry, Pragya Sinha, Venkatesh Hegde, Linghua Wang, Ananta V. Yanamandra, Neil D. Gross, Amit Agrawal, Xiuning Le, Jeffrey N. Myers, Maura L. Gillison, Stephen Y. Lai
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundHuman papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HPV+ HNSCC) is a disease that has moderate response to anti-PD-1/L1 immune checkpoint blockade, with the response rates less than 20% and median progression-free sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d22f979d55262a3b52dc2a779a70d88f
https://doi.org/10.1136/jitc-2021-sitc2021.754
https://doi.org/10.1136/jitc-2021-sitc2021.754
Publikováno v:
The FASEB Journal. 32
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33a6ebca892e3c7c4e43a7eff5312705
https://doi.org/10.1096/fasebj.2018.32.1_supplement.663.41
https://doi.org/10.1096/fasebj.2018.32.1_supplement.663.41